Method of inhibiting hepatitis B virus
US6037351A · kind A · utility
2Cited by
4References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 1996 |
| Grant date | Mar 14, 2000 |
| Priority date | — |
| Expiry date | Jul 11, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is disclosed for the treatment of hepatitis B virus (HBV) infections which comprises administering to the infected host an N-alkyl derivative of 1,5-dideoxy-1,5-imino-D-glucitol in which the alkyl group contains from 3 to 6 carbon atoms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.